2 results
Approved WMORecruiting
The primary endopoint is to determine whether ketoconazole/octreotide combination therapy, followed by octreotide monotherapy, is an effective treatment for Cushing's disease. Secundary endpoints address the effects of this therapy on bone…
Approved WMORecruiting
To determine if SSA are effective in decreasing transfusion requirements and improving quality of life while being cost-effective.